CD44 and pancreatic neoplasm: Sántha et al. [18] studied the expression of CD44, CD133, and ALDH1 in pancreatic cancer cells as part of a morphological subtyping scheme and found significant differences in marker expression between proposed subtypes that correlated with other morphological and immunohistochemical features.